Paper II — 2024 December (Supplementary) (2019 Scheme) — Qxx
2 min read
Paper II
2024 December (Supplementary) (2019 Scheme) · 100 marks · 180 min
Question
Assertion (A): Cyclosporine is used as a part of induction regimen to prevent organ transplant rejection.
Reason (R): Cyclosporine inhibits TNFα secreted by activated macrophages and other immune cells.
a) Both A and R are true, and R is the correct explanation of A
c) A is true, but R is false
b) Both A and R are true, and R is not the correct explanation of A
d) A is false, but R is true
(PTO)
Qxx1 marksMCQs
Answer
Correct answer: c) A is true, but R is false
A is true — cyclosporine is indeed used as part of induction/maintenance immunosuppressive regimens to prevent organ transplant rejection. R is false: cyclosporine does not inhibit TNF-alpha (that is the mechanism of biologic agents such as infliximab/etanercept) — it binds the immunophilin cyclophilin, and the resulting complex inhibits calcineurin, blocking NFAT-mediated IL-2 gene transcription and thereby T-cell activation.